Ireland in the IRP Crossfire

Report
15 Pages
August 2026
Region: Ireland
GlobalData
ID: 6286123

Ireland in the IRP Crossfire

Summary

Ireland's decision to exclude the UK from its international reference pricing (IRP) basket from 2027 will exert mild downward pressure on achievable ex-manufacturer prices for innovative medicines, a the analyst analysis of POLI data across 22 recently reimbursed products finds.

Key findings
Outlook and Implications
Disclaimer

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

Request Quote or Invoice

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4631EUR$4,995USD£3,874GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€9262EUR$9,990USD£7,747GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13893EUR$14,985USD£11,621GBP

Ireland in the IRP Crossfire

Summary

Table of Contents

Related Reports

Ireland Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market Analysis to 2030 (H1 2026)

Europe Renewable Energy Policy Handbook 2026

Ireland E-commerce - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

Europe Data Center Server - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

Industrial Hose Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis